First Population-Wide Peer-Reviewed Study Finds COVID-19 “Vaccines” Increase Risk of Multiple Cancers --- CONFIRMS Fears of “Turbo Cancer” Epidemic
For the first time, a population-wide cohort of nearly 300,000 people tracked over 30 months has revealed that the so-called “safe and effective” COVID-19 shots are linked to alarming spikes in multiple forms of cancer.
Researchers followed every resident aged 11 and older in Italy’s Pescara province from June 2021 through December 2023, examining hospital records and adjusting for age, sex, prior health conditions, and even prior COVID infection.
The researchers allegedly found that those who received at least one vaccine dose had a much lower risk of dying from any cause compared to the unvaccinated, and this protective effect was even stronger in people who had three or more doses.
When looking at cancer, the picture was less clear. People who had been vaccinated appeared somewhat more likely to be hospitalized with a new cancer diagnosis than those who were unvaccinated, particularly for cancers of the breast, bladder, and colon.
However, this increased risk was only evident in people who had never been infected with COVID-19, and it disappeared---or even reversed—when the analysis required at least twelve months to pass between vaccination and a hospital admission for cancer.
Hospitalizations for cancer were 35% higher in vaccinated individuals versus the unvaccinated (HR 1.23).
The link was strongest in men and in those with no prior COVID infection.
Overall Cancer Risk: +23% after just one dose
Breast Cancer: +54% risk after vaccination
Bladder Cancer: +62% increased risk
Colorectal Cancer: +35% increased risk
Even after multiple doses, the risks remained elevated across the board.
Despite strong “healthy vaccinee bias” (explained below), the study still found multiple increases in cancer hospitalizations among vaccinated individuals.
Overall cancer risk:
+23% increased risk after ≥1 dose (HR 1.23, 95% CI 1.11--1.37) (statistically significant)
+9% increased risk after ≥3 doses (HR 1.09, 95% CI 1.02--1.16) (statistically significant)
Anecdotal reports suggested an association between SARS-CoV-2 vaccination and some cancers, but no formal assessment has been published. This population-wide cohort analysis was aimed at evaluating the risk of all-cause death and cancer ...
pmc.ncbi.nlm.nih.gov
www.vigilantfox.com
